HOME >> MEDICINE >> NEWS
The worldwide prevalence of glaucoma is increasing

Early diagnosis of glaucoma is essential to prevent irreversible visual impairment, according to a Seminar in this week's issue of THE LANCET.

Glaucoma is a group of disorders that progressively damage the optic nerve in the eye and without treatment can cause visual disability and eventual blindness. Glaucoma affects more than 66 million people worldwide and is the second leading cause of blindness. In the USA, health costs from glaucoma-related blindness have been estimated to be in excess of US $1.5billion a year, and the magnitude of the problem will increase as the population ages.

Robert N. Weinreb from the University of California San Diego, USA, and Peng Tee Khaw from the Moorfields Eye Hospital and Institute of Ophthalmology, London, UK, address primary open-angle glaucoma, an age-related and insidious form of the disease.

Loss of vision from glaucoma can be limited by currently available therapies if the disease is identified in its early stages. However, most cases are not discovered until vision has already been permanently affected, because clinical signs of early glaucoma may be subtle, even to an eye specialist. Although the risk of developing glaucoma increases substantially with the level of pressure in the eye and increasing age, the authors note that measurement of this pressure alone is not an effective method for diagnosis. Assessments of the optic disc, retinal nerve fibre layer, and visual function provide complementary information and new imaging and psychophysical tests can improve both detection and monitoring of the progression of the disease.

Weinreb and Khaw conclude that examination of the optic nerve is an essential component of the adult eye assessment and is the most effective way to identify individuals with glaucoma. The authors stress "the importance of early diagnosis to initiate pressure-lowering treatment and early detection of progression to advance this treatment."


'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
20-May-2004


Page: 1

Related medicine news :

1. New estimates for the causes of child deaths worldwide
2. Study provides new estimates of the causes of child mortality worldwide
3. Urgent action required to prevent 500k deaths/yr worldwide from pregnancy-related causes
4. Stevens Cattabiani helps link doctors, hospitals worldwide
5. Use of rubella vaccine is growing worldwide, but more work remains
6. Caloric sweetener use grows worldwide; soft drinks are chief culprit, study shows
7. Nearly 5 million deaths worldwide caused by smoking
8. Italy now faces worldwide storm of protest over fertility proposals
9. CDC MMWR: New data on TB epidemics worldwide
10. Brain image database benefits research and education worldwide
11. Is a one child policy worldwide the solution to human population growth?

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: The worldwide prevalence glaucoma increasing

(Date:10/20/2014)... 20, 2014 With a mere 19 ... Crist made a brief fundraising stop at the ... , Fresh from a debate last night with his ... stage for the first seven minutes because Crist had ... described the incident in one word: "weird." , Before ...
(Date:10/20/2014)... 2014 ASCNYC (ascnyc.org) is a ... New Yorkers living with HIV/AIDS and other chronic ... recovery and self-sufficiency. Each year, ASCNYC spotlights selected ... through their tireless efforts. , Savills Studley ... has been selected as this year’s honoree for ...
(Date:10/20/2014)... IN (PRWEB) October 20, 2014 ... Start, a secure cloud solution that enables healthcare ... of the ultimate healthcare-specific customer relationship management (“CRM”) ... meet the unique needs of the healthcare industry, ... experience for providers and patients by combining healthcare ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 My Clients ... management software application. The new module enables easy ... receive full life-cycle quality care. , This application allows ... within their practice, attach a to-do item to a ... and even set up reoccurring reminders for follow-ups. ...
(Date:10/20/2014)... 20, 2014 Myoderm ... Assistant Director of their CentralSource service. ... the innovative turnkey drug sourcing, distribution, and management ... over 12 years of industry experience, in both ... the peak of their international success to help ...
Breaking Medicine News(10 mins):Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 2Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 3Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 2Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 3Health News:Healthcare Relationship Management (HRM) Leader hc1.com® Launches hc1® Quick Start™ 2Health News:My Clients Plus Announces New Workflow Management Software 2Health News:Myoderm Hires Matthew Voicheck to Lead Turnkey Drug Sourcing Service 2
(Date:10/17/2014)... 17, 2014 With the recent changes ... has come across several challenges in creating and ... globalization.  The Medical Affairs ... to providing benchmarking and best practices across critical ... a service composed of three stages: 1) member-driven ...
(Date:10/17/2014)... Research ... addition of the  "China Interventional Cardiovascular Device ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) The ... China impacted by accelerated aging ... dietary habit, way of working and other ...
(Date:10/17/2014)... , October 17, 2014 Investor-Edge ... Inc. (NASDAQ: ARNA ), NPS Pharmaceuticals Inc. ... XOMA ), Momenta Pharmaceuticals Inc. (NASDAQ: ... Free research on these five companies can be accessed ... on Thursday, October 16, 2014, ended on a mixed ...
Breaking Medicine Technology:Early Key Findings from the Medical Affairs Consortium Research 2China Interventional Cardiovascular Device Industry Report 2014-2017 2China Interventional Cardiovascular Device Industry Report 2014-2017 3Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 2Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 3Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 4Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 5
Cached News: